Serum levels of IL-17 were elevated in patients with SS when compared with that in controls, and PBMCs treated with IL-27 showed reduced percentage of CD4+IL-17A+ T cells, downregulated expression of IL-17A, and increased percentage of Treg cells (130, 131). Here, CD4 is linked to synovial sarcoma.